Therefore, understanding how PA28γ enhances the proteolytic activity of the T-L site as shown here would provide a mechanistic understanding and platform to design drugs that could be used to potentially treat Huntington’s disease. This evidence concerns the gene PSME3 and juvenile Huntington disease.